Skip to content
Humira

Humira

Adalimumab

Adalimumab injectable solution for rheumatoid arthritis and psoriatic arthritis. A biologic that blocks TNF-alpha, a molecule that fuels joint inflammation.

All strengths and pack prices
StrengthPackPricePer unit
20mg / 0.4ml2 auto-injectors$604.00$302.00
20mg / 0.4ml4 auto-injectors$1169.00$292.25
20mg / 0.4ml8 auto-injectors$2283.00$285.38
40mg / 0.8ml2 auto-injectors$790.00$395.00
40mg / 0.8ml4 auto-injectors$1530.00$382.50
40mg / 0.8ml8 auto-injectors$2990.00$373.75
Active ingredient
Adalimumab
Route
Subcutaneous use
Form
Injectable Solution
Strengths
20mg / 0.4ml · 40mg / 0.8ml

This listing uses Humira as a reference name. A generic equivalent is supplied; its exact brand and manufacturer are confirmed before supply.

Humira details

Alternative names
adalimumab
Therapeutic class
Tumour Necrosis Factor (TNF) Blocker
Pharmacological class
Monoclonal Antibody
Contraindications
severe active infection; moderate to severe congestive heart failure
Minor side effects
injection site pain; headache; rash
Moderate side effects
upper respiratory tract infection; sinusitis; nausea
Dosage forms
Injectable Solution
Administration route
Subcutaneous use
Originator
AbbVie
Onset time
2–4 weeks
Duration
10–14 days
Storage instructions
Store between 2°C and 8°C. Do not freeze.
Drug interactions
Abatacept; Anakinra; Live Vaccines
Age restrictions
Approved for children over two years and adults based on indication.
Serious side effects

severe systemic sepsis, requires immediate medical attention; malignancy development, requires immediate medical attention; demyelinating disease activation, requires immediate medical attention

Patient summary

Adalimumab injectable solution for rheumatoid arthritis and psoriatic arthritis. A biologic that blocks TNF-alpha, a molecule that fuels joint inflammation.

Mechanism of action

Binds specifically to TNF-alpha, neutralising its interaction with cell surface receptors to halt the inflammatory cascade.

Pregnancy and breastfeeding

Pregnancy: Consult clinician. Breastfeeding: Confirm breastfeeding suitability with a qualified clinician or pharmacist before use.

What you will receive

Humira is used here as a reference originator brand name to identify the medicine. We are not affiliated with the brand owner, and this listing does not offer the originator product.

  • The supplied product is a generic equivalent containing Adalimumab, not the originator brand shown as the reference.
  • The exact generic brand, manufacturer and dispatch location are confirmed based on the product, destination and available manufacturer or partner warehouse.
  • Check the final product details at checkout before confirming an order.

How we compare medicine brands and generics